HPV16 E6 Promotes Breast Cancer Proliferation via Upregulation of COX-2 Expression

Table 2

HPV16 E6 and COX-2 DNA expression in invasive ductal breast cancer.

Sample	Gender	Age	CT GAPDH (mean ± SD)	CT of HPV16E6 (mean ± SD)	CT of COX-2 (mean ± SD)
1	Female	61		Undetermined
2	Female	35
3	Female	39		Undetermined
4	Female	59
5	Female	35
6	Female	73		Undetermined
7	Female	50		Undetermined
8	Female	64
9	Female	62		Undetermined
10	Female	63		Undetermined
11	Female	63		Undetermined
12	Female	66		Undetermined
13	Female	51		Undetermined
14	Female	43		Undetermined
15	Female	45		Undetermined
16	Female	68
17	Female	74		Undetermined
18	Female	42
19	Female	53		Undetermined
20	Female	44		Undetermined
21	Female	53
22	Female	41		Undetermined
23	Female	59		Undetermined
24	Female	42		Undetermined
25	Female	44		Undetermined
26	Female	33
27	Female	71		Undetermined
28	Female	60
29	Female	54		Undetermined
30	Female	32
31	Female	80		Undetermined
32	Female	53		Undetermined
33	Female	85		Undetermined
34	Female	43		Undetermined
35	Female	60
36	Female	61		Undetermined
37	Female	77		Undetermined
38	Female	56		Undetermined
39	Female	59
40	Female	32
41	Female	68
42	Female	64		Undetermined
43	Female	60		Undetermined
44	Female	58		Undetermined
45	Female	78		Undetermined
46	Female	60		Undetermined
47	Female	58		Undetermined
48	Female	42
49	Female	25		Undetermined
50	Female	57		Undetermined